CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Charles River Laboratories International, Inc.

Equities

CRL

US1598641074

Market Closed - Nyse Other stock markets 21:00:02 13/06/2025 BST			5-day change	1st Jan Change
149.45 ^USD	-1.61%		+3.28%	-19.04%

06-09	Charles River Laboratories International, Inc. Presents at 45th Annual William Blair Growth Stock Conference, Jun-03-2025 10:00 AM
06-04	Charles River Laboratories International, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 10:30 AM

Charles River Laboratories International, Inc. Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-12-2023 10:10 AM

Published on 12/09/2023 at 15:10

Presenter Speech
Tejas Savant (Analysts)

All right. Thanks, everyone, for joining us. My name is Tejas Savant and I'm the Life Science Tools and Diagnostics Analyst at Morgan Stanley. Before we begin,

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc. Presents at 45th Annual William Blair Growth Stock Conference, Jun-03-2025 10:00 AM	06-09
Charles River Laboratories International, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 10:30 AM	06-04
Charles River Laboratories International to Seek Strategic M&A	06-03	CI
Charles River Laboratories, CHDI Foundation Extend Collaboration	05-28	MT
Charles River Laboratories International Extend Drug Discovery Partnership With CHDI Foundation	05-28	RE
Charles River Laboratories International CEO James C. Foster's Employment Extended Until February 2027 - SEC Filing	05-23	RE
Declaration of Voting Results by Charles River Laboratories International	05-23	CI
Trump's Tariff Blitz Roils Markets, Targets EU and Apple	05-23
Redburn Atlantic Upgrades Charles River Laboratories International to Buy From Neutral, Adjusts Price Target to $182 From $188	05-23	MT
Analyst recommendations: Crowdstrike, AMD, Boeing, Intuit, Okta…	05-23
Charles River Laboratories International, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 08:40 AM	05-14
TD Cowen Upgrades Charles River Laboratories International to Buy From Hold, Adjusts PT to $179 From $105	05-14	MT
Morgan Stanley Cuts Price Target on Charles River Laboratories International to $168 From $184	05-09	MT
UBS Cuts Price Target on Charles River Laboratories International to $150 From $185, Keeps Neutral Rating	05-08	MT
Barclays Adjusts Price Target on Charles River Laboratories International to $155 From $145, Maintains Equalweight Rating	05-08	MT
Deutsche Bank Adjusts Price Target on Charles River Laboratories International to $180 From $140, Maintains Buy Rating	05-08	MT
London Calling: Markets Jump	05-08
Jefferies Adjusts Price Target on Charles River Laboratories International to $142 From $100, Maintains Hold Rating	05-08	MT
JPMorgan Adjusts Price Target on Charles River Laboratories International to $145 From $165, Maintains Neutral Rating	05-08	MT
Citigroup Adjusts Price Target on Charles River Laboratories International to $150 From $175, Maintains Neutral Rating	05-08	MT
Deutsche Bank Adjusts Charles River Laboratories International Price Target to $180 From $140, Maintains Buy Rating	05-08	MT
Evercore ISI Upgrades Charles River Laboratories International to Outperform From In Line, Adjusts PT to $170 From $235	05-08	MT
Analyst recommendations: AMD, Walt Disney, Applovin, Ionq, Uber...	05-08
Equity Markets Close Higher as Fed Decides to Keep Fund Rates Unchanged	05-07	MT
Sector Update: Health Care Stocks Rise Late Afternoon	05-07	MT